# Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer

> **NCT02696759** · NA · TERMINATED · sponsor: **University of Arkansas** · enrollment: 15 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Blood & Fecal Collection

## Key facts

- **NCT ID:** NCT02696759
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07
- **Primary completion:** 2021-08
- **Final completion:** 2021-08
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** PI left institution in 2019. Study was placed on hold at that time and will not be resuming. No data analysis was performed.
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02696759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02696759, "Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02696759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*